Mirador Therapeutics Secures Exclusive Worldwide License for Anti-C5a Antibody KP-301 from Kira Pharmaceuticals

Leila Ahmed North America Legal Chronicle
Tagged:

Ropes & Gray has advised Mirador Therapeutics in its exclusive worldwide license agreement with Kira Pharmaceuticals. Mirador Therapeutics, Inc., a clinical-stage precision medicine company, has entered…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here